MedCity News December 29, 2024
Through collaboration between regulators and healthcare stakeholders, telehealth prescribing can continue to expand treatment access while maintaining proven safety standards.
Telehealth prescribing has reshaped behavioral healthcare delivery across the U.S., making essential medications more accessible than ever before. Recent data shows the proportion of Medicaid beneficiaries accessing buprenorphine treatment through telehealth increased year over year from 2% to over 15% in states like Kentucky and Ohio.
While the Drug Enforcement Administration has extended virtual prescribing flexibilities through 2025, the lack of permanent regulations creates uncertainty for behavioral health providers and patients who rely on these services. The continuity of care for those receiving controlled substances through telehealth — from addiction treatment medications to behavioral health prescriptions — hangs in the...
Today's Sponsors
Today's Sponsor